ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements
Biopol Chemicals Limited regularised the appointment of Mr. Sukhomoy Das as an Independent Director for a five-year term, effective June 11, 2026, following shareholder approval.
Biopol Chemicals Limited held its 3rd Annual General Meeting on September 22, 2026, via video conferencing. The meeting transacted ordinary and special business items.
Biopol Chemicals Limited participated in the 53rd Dye+Chem Bangladesh 2026 International Expo held in Dhaka from September 2 to September 5, 2026.
Biopol Chemicals Limited clarified that recent share price movements are entirely market-driven. The company confirmed it has no undisclosed material information affecting trading volume or price.
Biopol Chemicals Limited issued notice for its 3rd Annual General Meeting on September 22, 2026 via video conferencing. The agenda includes financial adoption and director appointments.
Biopol Chemicals Limited has appointed M/s. M.K Chokshi & Associates as Secretarial Auditor and Nikhar Agarwal & Co. as Internal Auditor for the financial year 2026-27.
Biopol Chemicals held its Board Meeting, approving the 3rd AGM notice, re-appointment of a director, and appointment of an Independent Director, Secretarial and Internal Auditors.
Mrs. Vandan Vij Sarkar has resigned as Non-Executive Non-Independent Director of Biopol Chemicals Limited. The resignation is effective from August 24, 2026, due to professional commitments.
Biopol Chemicals appointed two new directors and reconstituted board committees. This strengthens governance and board composition.
Biopol Chemicals Limited submitted its annual SDD compliance certificate for FY 2025-2026. The auditor confirmed maintained databases and captured twelve required events with no non-compliance observed.
Biopol Chemicals Limited approved shifting its registered office to Vatva, Ahmedabad, effective May 22, 2026. This administrative relocation remains within local city limits.
Biopol Chemicals Limited reported a total income of ₹81.37 Crore for the financial year ended March 31, 2026, with a net profit of ₹8.97 Crore. The Board approved the results with an unmodified audit opinion. The company also confirmed it does not meet the 'Large Corporate' criteria for the period.
Biopol Chemicals Limited submitted its Regulation 32 statement confirming the full utilization of ₹31.26 Crore raised via its SME IPO. The Audit Committee reviewed the report, confirming zero deviation from the objects stated in the prospectus dated February 11, 2026. Funds were deployed for land acquisition, debt repayment, and general corporate purposes.
Biopol Chemicals Ltd reported revenue from operations of ₹49.5 Cr (+46.4% YoY) and net profit of ₹6 Cr (+100.0% YoY) for H2 FY26.
Biopol Chemicals Limited reported a total income of ₹81.37 Crore for the financial year ended March 31, 2026, with a net profit of ₹8.97 Crore. The Board approved these audited results in its meeting on April 30, 2026, noting an unmodified audit opinion from statutory auditors.
Biopol Chemicals Limited has informed the exchange regarding the non-applicability of Corporate Governance Report for the quarter ended March 31, 2026. As an SME-listed entity below regulatory capital and net worth thresholds, it is exempt from these provisions under Regulation 15 of SEBI LODR.
Biopol Chemicals Limited confirmed it does not meet the SEBI criteria for a 'Large Corporate' as of March 31, 2026. Consequently, the company is exempt from the specific debt-raising and disclosure requirements mandated for large corporate entities for the financial year ended 2025-26.
Biopol Chemicals Limited announced the outcomes of its board meeting held on April 15, 2026. The board approved the appointment of M/s. Nikhar Agarwal & Co. as Internal Auditors and M/s. M.K Chokshi & Associates as Secretarial Auditors for the Financial Year 2025-2026.